PACB

PACIFIC BIOSCIENCES CALIF IN

PACB·69404D108·US·Common Stock·Healthcare - Medical Devices-13D/G

PACB (PACIFIC BIOSCIENCES CALIF IN) is held by 124 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($54.3M), ARK Investment Management LLC ($50M), SOFTBANK GROUP CORP. ($34.4M). Net institutional sentiment: Mixed.

124
Holders
(13 Elite)
$299.8M
Total Value
53% (117)
Consensus
62 buying - 55 selling
13F: Insider & Congress: Updated regularly
PACB

Smart Money Verdict

View all
Loading verdict
Held by 124 funds
13 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Aug 18, 2026 · Activists Aug 14, 2026 · Congress none

InsiderVMVan Oene MarkSell $30KAug 17, 2026
ActivistARK Investment Management LLCARK Investment Management LLC9.6%Aug 14, 2026
InsiderGIGibson James R IISell $121KApr 1, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
32.3M(+28.0%)$54.3M0.0%-10.76%
37
Decreased
29.8M(-17.9%)$50M0.3%-84.77%
0
Unchanged
20.5M$34.4M0.2%-12.85%
0
Increased
13.4M(+4.9%)$22.5M0.0%+2.13%
30
Increased
7.6M(+9.1%)$12.8M0.0%-82.64%
31
Decreased
6M(-14.6%)$10.1M0.0%-92.07%
0
Decreased
6M(-14.6%)$10M0.1%-92.00%
0
Decreased
6M(-2.6%)$10M0.0%-81.41%
0
Increased
4.8M(+1575.6%)$8M0.0%-7.31%
44
Increased
4.2M(+20.9%)$7.1M0.0%-5.14%
33
Increased
4.2M(+15.7%)$7.1M0.0%-9.47%
31
Decreased
4M(-19.0%)$6.7M0.0%+11.61%
0
Increased
3.2M(+226.8%)$5.4M0.0%-8.19%
44
Increased
2.8M(+80.6%)$4.8M0.0%+4.15%
41
Decreased
2.7M(-6.8%)$4.5M0.0%+2.63%
0
Increased
2.7M(+10.3%)$4.5M0.0%-82.54%
30
Increased
2.4M(+10.4%)$4M0.0%-81.38%
29
Increased
2.2M(+10.1%)$3.7M0.0%+1.65%
29
Increased
2.1M(+23.9%)$3.6M0.0%-15.84%
32
Decreased
1.3M(-19.1%)$2.3M0.0%+0.42%
0

Showing 1-20 of 133

1 / 7
PACBPACBPACIFIC BIOSCIENCES CALIF IN

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used